Full Text
The Full Text of this article is available as a PDF (24.1 KB).
Footnotes
Membership of the Biomarkers Group Comprises: Professor Robin Leake (Biochemistry, Glasgow University – Chairman), Dr Liz Anderson (Clinical Research, Christie Hospital, Manchester), Professor Mitch Dowsett (Endocrinology, Royal Marsden Hospital, London), Dr Ray Iles (St Bartholomew's Hospital, London), Professor Rob Nicholson, Tenovus Unit, Pharmacology, Cardiff), Professor John Robertson (Surgery, Nottingham), Dr Rosemary Walker (Pathology, Leicester)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes D. M., Millis R. R., Beex L. V., Thorpe S. M., Leake R. E. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. Eur J Cancer. 1998 Oct;34(11):1677–1682. doi: 10.1016/s0959-8049(98)00149-x. [DOI] [PubMed] [Google Scholar]
- Dowsett M. Improved prognosis for biomarkers in breast cancer. Lancet. 1998 Jun 13;351(9118):1753–1754. doi: 10.1016/S0140-6736(05)78743-2. [DOI] [PubMed] [Google Scholar]
- Elledge R. M., Osborne C. K. Oestrogen receptors and breast cancer. BMJ. 1997 Jun 28;314(7098):1843–1844. doi: 10.1136/bmj.314.7098.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hawkins R. A., Roberts M. M., Forrest A. P. Oestrogen receptors and breast cancer: current status. Br J Surg. 1980 Mar;67(3):153–169. doi: 10.1002/bjs.1800670302. [DOI] [PubMed] [Google Scholar]
- Helzlsouer K. J. Serological markers of cancer and their applications in clinical trials. Cancer Res. 1994 Apr 1;54(7 Suppl):2011s–2014s. [PubMed] [Google Scholar]
- Romain S., Lainé Bidron C., Martin P. M., Magdelenat H. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group. Eur J Cancer. 1995;31A(3):411–417. doi: 10.1016/0959-8049(94)00496-r. [DOI] [PubMed] [Google Scholar]
- Sweep C. G., Geurts-Moespot J., Grebenschikov N., de Witte J. H., Heuvel J. J., Schmitt M., Duffy M. J., Jänicke F., Kramer M. D., Foekens J. A. External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts. Br J Cancer. 1998 Dec;78(11):1434–1441. doi: 10.1038/bjc.1998.704. [DOI] [PMC free article] [PubMed] [Google Scholar]